# imatinib mesylate

NDC: 0832-0533
Generic name: imatinib mesylate
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240517
Marketing ended: 20270131
FDA application: ANDA212135

## Active ingredients

- IMATINIB MESYLATE: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0832-0533"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0832-0533
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d07ac08-962e-41a8-8a3c-50febc8c5f34